{"transactions":[{"id":1434605,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common shares","published_at":"2024-08-13T14:55:35.000Z","date":"2024-08-12","kind":"purchase","planned":false,"acquired":true,"shares":1600,"price":3.13,"value":5008.0,"ownership":{"direct":true},"balance_after":3100,"source":{"system":"sec-edgar","filing":"0001855763-24-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576324000013/primary_doc.xml","form_type":"4"}},{"id":1446138,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-30T15:32:13.000Z","date":"2024-07-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27000,"derivative":{"exercise_price":3.39,"exercise_date":"2024-07-26","expiration_date":"2029-07-26","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001348362-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000134836224000003/primary_doc.xml","form_type":"4"}},{"id":1520425,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-05-10T21:16:29.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":2.36,"exercise_date":"2024-04-26","expiration_date":"2029-04-26","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-24-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576324000009/primary_doc.xml","form_type":"4"}},{"id":1823413,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-25T17:44:44.000Z","date":"2023-07-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":0.87,"exercise_date":"2023-07-25","expiration_date":"2028-07-25","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001855763-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576323000002/primary_doc.xml","form_type":"4"}},{"id":1989870,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-02-27T15:52:10.000Z","date":"2023-02-09","kind":"purchase","acquired":true,"shares":1500,"price":2.8446,"value":4266.9,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001855763-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576323000001/primary_doc.xml","form_type":"4"}},{"id":2137555,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-13T21:16:36.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000,"derivative":{"exercise_price":1.96,"exercise_date":"2022-10-12","expiration_date":"2027-10-12","underlying":"Common Shares","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001855763-22-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576322000015/primary_doc.xml","form_type":"4"}},{"id":2165206,"issuer":{"id":7641,"kind":"organization","name":"Lexaria Bioscience Corp."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-09-06T16:53:24.000Z","date":"2022-09-02","kind":"grant","acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3400,"derivative":{"exercise_price":3.04,"exercise_date":"2022-09-02","expiration_date":"2027-09-02","underlying":"Common Shares","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001855763-22-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1348362/000185576322000012/primary_doc.xml","form_type":"4"}},{"id":3199214,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T20:31:28.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 100,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 75,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.26,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-20-009125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924320009125/doc4.xml","form_type":"4"}},{"id":3404352,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-01T01:30:32.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first and second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-19-024432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319024432/doc4.xml","form_type":"4"}},{"id":3515043,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-05-22T20:12:04.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":1914,"price":1.9114,"value":3658.4196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":88662,"source":{"system":"sec-edgar","filing":"0001562180-19-003055","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000156218019003055/primarydocument.xml","form_type":"4"}},{"id":3515042,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-05-22T20:12:04.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":7623,"price":1.9616,"value":14953.2768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":90576,"source":{"system":"sec-edgar","filing":"0001562180-19-003055","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000156218019003055/primarydocument.xml","form_type":"4"}},{"id":3590351,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T20:24:57.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-008141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319008141/doc4.xml","form_type":"4"}},{"id":3590350,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-03-18T20:24:57.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":98199,"source":{"system":"sec-edgar","filing":"0000899243-19-008141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319008141/doc4.xml","form_type":"4"}},{"id":3816913,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2018-09-14T00:00:25.000Z","date":"2018-09-12","kind":"purchase","acquired":true,"shares":16632,"price":5.019,"value":83476.008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.97 to $5.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":78199,"source":{"system":"sec-edgar","filing":"0000899243-18-024470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318024470/doc4.xml","form_type":"4"}},{"id":3816912,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2018-09-14T00:00:25.000Z","date":"2018-09-11","kind":"purchase","acquired":true,"shares":17048,"price":4.556,"value":77670.688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $4.47 to $4.70. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61567,"source":{"system":"sec-edgar","filing":"0000899243-18-024470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318024470/doc4.xml","form_type":"4"}},{"id":3821894,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2018-09-08T00:00:24.000Z","date":"2018-09-05","kind":"purchase","acquired":true,"shares":805,"price":3.966,"value":3192.63,"ownership":{"direct":false,"nature":"By Spouse's IRA"},"balance_after":805,"source":{"system":"sec-edgar","filing":"0000899243-18-024043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318024043/doc4.xml","form_type":"4"}},{"id":3994493,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T22:46:31.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 24,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 13, 2019, with the remaining 18,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":24000,"derivative":{"exercise_price":4.83,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000899243-18-007642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318007642/doc4.xml","form_type":"4"}},{"id":3994492,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2018-03-15T22:46:31.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":44519,"source":{"system":"sec-edgar","filing":"0000899243-18-007642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318007642/doc4.xml","form_type":"4"}},{"id":4171265,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-06T22:10:20.000Z","date":"2017-11-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock one quarter of which will become fully vested and exercisable on 11/6/2018, with the remaining 37,500 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.21,"expiration_date":"2027-11-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-17-025437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317025437/doc4.xml","form_type":"4"}},{"id":4302866,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T20:06:19.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 52,500 shares of the Issuer's Common Stock. 36,000 shares will vest ratably each month over three years beginning on May 24, 2017 (the \"grant date\"). 16,500 shares will vest on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":52500,"derivative":{"exercise_price":5.5,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000899243-17-014541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317014541/doc4.xml","form_type":"4"}},{"id":4324526,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":88335,"kind":"person","name":"TURKEL CATHERINE C.","position":1,"cik":"0001705278","reported_name":"TURKEL CATHERINE C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2017-05-12T00:33:08.000Z","date":"2017-05-10","kind":"purchase","acquired":true,"shares":11111,"price":9.99,"value":110998.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017."}],"balance_after":24519,"source":{"system":"sec-edgar","filing":"0000899243-17-012934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317012934/doc4.xml","form_type":"4"}}]}